// App-Quantinova.ai

165 : Identification Of Novel Viral Single Nucleotide Variants Associated With Baseline HBV DNA Levels And HBeAg Status In Chronic Hepatitis B Patients.

Researchers

Presenter

  • Kosh Agarwal

Principal Investigators

  • Maurizia R. Brunetto

  • Won Young Tak

  • Ondrej Podlaha

  • Biao Li

  • Luting Zhuo

  • Neeru Bhardwaj

  • Kathryn M. Kitrinos

  • Anuj Gaggar

  • Zhaoshi Jiang

  • Rajiv Mehta

  • Alex J. Thompson

  • Edward J. Gane

Medical Centers

  • Gilead Sciences, Inc., Foster City, CA

  • Institute of Liver Studies, Kings CollegeHospital NHS Trust, London , United Kingdom

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

  • Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea, Republic Of,

  • Department of Gastroenterology, Surat Institute of Medical Sciences, Surat, India

  • Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Melbourne, VIC, Australia

  • St Vincents Hospital University of Melbourne, Fitzroy, VIC, Australia

  • Auckland Clinical Studies Limited, Auckland, New Zealand

Locations

  • United States

  • United Kingdom

  • Italy

  • Republic of South Korea

  • India

  • Australia

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis B

Biomarkers

  • Angiomodulin

  • Hepatitis B e antigen

  • Serum hepatitis B virus DNA

Drug/Treatment

  • Tenofovir disoproxil fumarate

  • Tenofovir alafenamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved